AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
USE OF LOSARTAN IN THE TREATMENT OF HYPERTENSIVE PATIENTS WITH A HISTORY OF COUGH INDUCED BY ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS
Authors: PASTER RZ SNAVELY DB SWEET AR DRAPER RA GOLDBERG AI SOFFER BA SWEET CS
Citation: Rz. Paster et al., USE OF LOSARTAN IN THE TREATMENT OF HYPERTENSIVE PATIENTS WITH A HISTORY OF COUGH INDUCED BY ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS, Clinical therapeutics, 20(5), 1998, pp. 978-989
REPORT OF A CONSENSUS CONFERENCE OF THE AMERICAN-COLLEGE-OF-CHEST-PHYSICIANS
Authors: MAKE BJ HILL NS GOLDBERG AI BACH JR CRINER GJ DUNNE PE GILMARTIN ME HEFFNER JE KACMAREK R KEENS TG MCINTURFF S ODONOHUE WJ OPPENHEIMER EA ROBERT D
Citation: Bj. Make et al., REPORT OF A CONSENSUS CONFERENCE OF THE AMERICAN-COLLEGE-OF-CHEST-PHYSICIANS, Chest, 113(5), 1998, pp. 289-344
VULNERABILITY AND DISCLOSURE IN SCIENCE - THE INTERPLAY BETWEEN AGENCY AND STRUCTURE
Authors: GOLDBERG AI
Citation: Ai. Goldberg, VULNERABILITY AND DISCLOSURE IN SCIENCE - THE INTERPLAY BETWEEN AGENCY AND STRUCTURE, Science communication, 19(2), 1997, pp. 99-123
SCIENTIFIC ARTICLES AND NATIONAL MEDICAL CULTURES - A COMPARISON OF RUSSIAN AND AMERICAN MEDICAL JOURNALS
Authors: GOLDBERG AI OIGENBLICK L RUBIN AHE
Citation: Ai. Goldberg et al., SCIENTIFIC ARTICLES AND NATIONAL MEDICAL CULTURES - A COMPARISON OF RUSSIAN AND AMERICAN MEDICAL JOURNALS, Scientometrics, 39(1), 1997, pp. 57-75
LOSARTAN-INDUCED HEPATOTOXICITY - REPLY
Authors: GOLDBERG AI SMITH IS STEPHENSON WP
Citation: Ai. Goldberg et al., LOSARTAN-INDUCED HEPATOTOXICITY - REPLY, JAMA, the journal of the American Medical Association, 278(19), 1997, pp. 1572-1572
FUNDAMENTAL REORGANIZATION IN SCIENTIFIC ADMINISTRATION - THE KHOZRASCHET INITIATIVE IN RUSSIAN APPLIED SCIENCE
Authors: OIGENBLICK L GOLDBERG AI HAREL G
Citation: L. Oigenblick et al., FUNDAMENTAL REORGANIZATION IN SCIENTIFIC ADMINISTRATION - THE KHOZRASCHET INITIATIVE IN RUSSIAN APPLIED SCIENCE, Science communication, 18(2), 1996, pp. 131-152
COMPARATIVE EFFECTS OF COMBINATION-DRUG THERAPY REGIMENS COMMENCING WITH EITHER LOSARTAN POTASSIUM, AN ANGIOTENSIN-II RECEPTOR ANTAGONIST, OR ENALAPRIL MALEATE FOR THE TREATMENT OF SEVERE HYPERTENSION
Authors: RUFF D GAZDICK LP BERMAN R GOLDBERG AI SWEET CS
Citation: D. Ruff et al., COMPARATIVE EFFECTS OF COMBINATION-DRUG THERAPY REGIMENS COMMENCING WITH EITHER LOSARTAN POTASSIUM, AN ANGIOTENSIN-II RECEPTOR ANTAGONIST, OR ENALAPRIL MALEATE FOR THE TREATMENT OF SEVERE HYPERTENSION, Journal of hypertension, 14(2), 1996, pp. 263-270
BASCH,MICHAEL,FRANZ - OBITUARY
Authors: GOLDBERG AI
Citation: Ai. Goldberg, BASCH,MICHAEL,FRANZ - OBITUARY, JAMA, the journal of the American Medical Association, 275(14), 1996, pp. 1137-1137
OUTCOMES OF HOME CARE FOR LIFE-SUPPORTED PERSONS - LONG-TERM OXYGEN AND PROLONGED MECHANICAL VENTILATION
Authors: GOLDBERG AI
Citation: Ai. Goldberg, OUTCOMES OF HOME CARE FOR LIFE-SUPPORTED PERSONS - LONG-TERM OXYGEN AND PROLONGED MECHANICAL VENTILATION, Chest, 109(3), 1996, pp. 595-596
A RANDOMIZED, DOUBLE-MASKED COMPARISON OF THE ANTIHYPERTENSIVE EFFICACY AND SAFETY OF COMBINATION THERAPY WITH LOSARTAN AND HYDROCHLOROTHIAZIDE VERSUS CAPTOPRIL AND HYDROCHLOROTHIAZIDE IN ELDERLY AND YOUNGER PATIENTS
Authors: CRITCHLEY JAJH GILCHRIST N IKEDA L DUBOIS C BRADSTREET DC SHAW WC GOLDBERG AI SWEET CS
Citation: Jajh. Critchley et al., A RANDOMIZED, DOUBLE-MASKED COMPARISON OF THE ANTIHYPERTENSIVE EFFICACY AND SAFETY OF COMBINATION THERAPY WITH LOSARTAN AND HYDROCHLOROTHIAZIDE VERSUS CAPTOPRIL AND HYDROCHLOROTHIAZIDE IN ELDERLY AND YOUNGER PATIENTS, Current therapeutic research, 57(5), 1996, pp. 392-407
LOSARTAN AND LOW-DOSE HYDROCHLOROTHIAZIDE IN PATIENTS WITH ESSENTIAL-HYPERTENSION - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF CONCOMITANTADMINISTRATION COMPARED WITH INDIVIDUAL COMPONENTS
Authors: MACKAY JH ARCURI KE GOLDBERG AI SNAPINN SM SWEET CS
Citation: Jh. Mackay et al., LOSARTAN AND LOW-DOSE HYDROCHLOROTHIAZIDE IN PATIENTS WITH ESSENTIAL-HYPERTENSION - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF CONCOMITANTADMINISTRATION COMPARED WITH INDIVIDUAL COMPONENTS, Archives of internal medicine, 156(3), 1996, pp. 278-285
RANDOMIZED, DOUBLE-BLIND, PARALLEL STUDY OF THE ANTIHYPERTENSIVE EFFICACY AND SAFETY OF LOSARTAN POTASSIUM COMPARED WITH FELODIPINE ER IN ELDERLY PATIENTS WITH MILD-TO-MODERATE HYPERTENSION
Authors: CHAN JCN CRITCHLEY JAJH LAPPE JT RASKIN SJ SNAVELY D GOLDBERG AI SWEET CS
Citation: Jcn. Chan et al., RANDOMIZED, DOUBLE-BLIND, PARALLEL STUDY OF THE ANTIHYPERTENSIVE EFFICACY AND SAFETY OF LOSARTAN POTASSIUM COMPARED WITH FELODIPINE ER IN ELDERLY PATIENTS WITH MILD-TO-MODERATE HYPERTENSION, Journal of human hypertension, 9(9), 1995, pp. 765-771
LOSARTAN POTASSIUM AS INITIAL THERAPY IN PATIENTS WITH SEVERE HYPERTENSION
Authors: DUNLAY MC FITZPATRICK V CHRYSANT S FRANCISCHETTI EA GOLDBERG AI SWEET CS
Citation: Mc. Dunlay et al., LOSARTAN POTASSIUM AS INITIAL THERAPY IN PATIENTS WITH SEVERE HYPERTENSION, Journal of human hypertension, 9(11), 1995, pp. 861-867
EFFICACY AND TOLERABILITY OF LOSARTAN POTASSIUM AND ATENOLOL IN PATIENTS WITH MILD-TO-MODERATE ESSENTIAL-HYPERTENSION
Authors: DAHLOF B KELLER SE MAKRIS L GOLDBERG AI SWEET CS LIM NY
Citation: B. Dahlof et al., EFFICACY AND TOLERABILITY OF LOSARTAN POTASSIUM AND ATENOLOL IN PATIENTS WITH MILD-TO-MODERATE ESSENTIAL-HYPERTENSION, American journal of hypertension, 8(6), 1995, pp. 578-583
ANTIHYPERTENSIVE EFFICACY AND TOLERABILITY OF ONCE-DAILY LOSARTAN POTASSIUM COMPARED WITH CAPTOPRIL IN PATIENTS WITH MILD-TO-MODERATE ESSENTIAL-HYPERTENSION
Authors: MALLION JM BRADSTREET DC MAKRIS L GOLDBERG AI HALASZ S SWEET CS LIM NY MADONNA O
Citation: Jm. Mallion et al., ANTIHYPERTENSIVE EFFICACY AND TOLERABILITY OF ONCE-DAILY LOSARTAN POTASSIUM COMPARED WITH CAPTOPRIL IN PATIENTS WITH MILD-TO-MODERATE ESSENTIAL-HYPERTENSION, Journal of hypertension, 13, 1995, pp. 35-41
SAFETY AND TOLERABILITY OF LOSARTAN COMPARED WITH ATENOLOL, FELODIPINE AND ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS
Authors: GOLDBERG AI DUNLAY MC SWEET CS
Citation: Ai. Goldberg et al., SAFETY AND TOLERABILITY OF LOSARTAN COMPARED WITH ATENOLOL, FELODIPINE AND ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS, Journal of hypertension, 13, 1995, pp. 77-80
EFFECTS OF LOSARTAN ON A BACKGROUND OF HYDROCHLOROTHIAZIDE IN PATIENTS WITH HYPERTENSION
Authors: SOFFER BA WRIGHT JT HOWARD J PRATT JH WIENS B GOLDBERG AI SWEET CS
Citation: Ba. Soffer et al., EFFECTS OF LOSARTAN ON A BACKGROUND OF HYDROCHLOROTHIAZIDE IN PATIENTS WITH HYPERTENSION, Hypertension, 26(1), 1995, pp. 112-117
A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PARALLEL STUDY OF VARIOUS DOSES OF LOSARTAN POTASSIUM COMPARED WITH ENALAPRIL MALEATE IN PATIENTS WITH ESSENTIAL-HYPERTENSION
Authors: GRADMAN AH ARCURI KE GOLDBERG AI IKEDA LS NELSON EB SNAVELY DB SWEET CS
Citation: Ah. Gradman et al., A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PARALLEL STUDY OF VARIOUS DOSES OF LOSARTAN POTASSIUM COMPARED WITH ENALAPRIL MALEATE IN PATIENTS WITH ESSENTIAL-HYPERTENSION, Hypertension, 25(6), 1995, pp. 1345-1350
PEDIATRIC HOME HEALTH - THE NEED FOR PHYSICIAN EDUCATION
Authors: GOLDBERG AI
Citation: Ai. Goldberg, PEDIATRIC HOME HEALTH - THE NEED FOR PHYSICIAN EDUCATION, Pediatrics, 95(6), 1995, pp. 928-930
HOME MEDICAL-CARE FOR CHILDREN - REPLY
Authors: GOLDBERG AI GIBSON LE GARDINER HG
Citation: Ai. Goldberg et al., HOME MEDICAL-CARE FOR CHILDREN - REPLY, The Journal of pediatrics, 127(2), 1995, pp. 332-332
STANDARDS FOR HOME CARE OF SICK CHILDREN - REPLY
Authors: GOLDBERG AI GARDNER MH GIBSON LE
Citation: Ai. Goldberg et al., STANDARDS FOR HOME CARE OF SICK CHILDREN - REPLY, The Journal of pediatrics, 126(4), 1995, pp. 682-682
BLOOD-PRESSURE EFFECTS OF THE ANGIOTENSIN-II RECEPTOR BLOCKER, LOSARTAN
Authors: WEBER MA BYYNY RL PRATT JH FAISON EP SNAVELY DB GOLDBERG AI NELSON EB
Citation: Ma. Weber et al., BLOOD-PRESSURE EFFECTS OF THE ANGIOTENSIN-II RECEPTOR BLOCKER, LOSARTAN, Archives of internal medicine, 155(4), 1995, pp. 405-411
SAFETY AND TOLERABILITY OF LOSARTAN POTASSIUM, AND ANGIOTENSIN-II RECEPTOR ANTAGONIST, COMPARED WITH HYDROCHLOROTHIAZIDE, ATENOLOL, FELODIPINE ER, AND ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS FOR THE TREATMENTOF SYSTEMIC HYPERTENSION
Authors: GOLDBERG AI DUNLAY MC SWEET CS
Citation: Ai. Goldberg et al., SAFETY AND TOLERABILITY OF LOSARTAN POTASSIUM, AND ANGIOTENSIN-II RECEPTOR ANTAGONIST, COMPARED WITH HYDROCHLOROTHIAZIDE, ATENOLOL, FELODIPINE ER, AND ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS FOR THE TREATMENTOF SYSTEMIC HYPERTENSION, The American journal of cardiology, 75(12), 1995, pp. 793-795
HOME CARE - THE NEXT FRONTIER OF PEDIATRIC PRACTICE
Authors: GOLDBERG AI GARDNER HG GIBSON LE
Citation: Ai. Goldberg et al., HOME CARE - THE NEXT FRONTIER OF PEDIATRIC PRACTICE, The Journal of pediatrics, 125(5), 1994, pp. 686-690
TECHNOLOGY-ASSESSMENT AND SUPPORT OF LIFE-SUSTAINING DEVICES IN-HOME CARE - THE HOME CARE PHYSICIAN PERSPECTIVE
Authors: GOLDBERG AI
Citation: Ai. Goldberg, TECHNOLOGY-ASSESSMENT AND SUPPORT OF LIFE-SUSTAINING DEVICES IN-HOME CARE - THE HOME CARE PHYSICIAN PERSPECTIVE, Chest, 105(5), 1994, pp. 1448-1453
Risultati: 1-25 | 26-30